Results 161 to 170 of about 407,965 (429)
ABSTRACT Background Diabetes mellitus (DM) is a well‐known risk factor for cardiovascular diseases, including coronary artery diseases (CAD). Complex percutaneous coronary intervention (PCI) such as PCI for bifurcation lesions often yields poor outcomes, especially in DM patients.
Subin Lim+31 more
wiley +1 more source
The revascularization strategy for severe calcification is one of the most pressing problems of modern percutaneous coronary interventions, since it is observed more and more often and significantly complicates traditional endovascular treatment ...
F. B. Shukurov+5 more
doaj +1 more source
Introduction and objectives: This study aims to investigate if the non-invasive assessment of coronary calcium score using multislice cardiac computerized tomography (MSCT) may anticipate the need for elective rotational atherectomy (RA) during ...
Guillermo Galeote+13 more
doaj +1 more source
Left Main Percutaneous Coronary Intervention
The introduction of drug-eluting stents and advances in catheter techniques have led to increasing acceptance of percutaneous coronary intervention (PCI) as a viable alternative to coronary artery bypass graft (CABG) for unprotected left main disease. Current guidelines state that it is reasonable to consider unprotected left main PCI in patients with ...
Paul S. Teirstein, Matthew J. Price
openaire +3 more sources
The optimal treatment of ischemic coronary artery disease (CAD) is still controversial. A number of randomized controlled trials (RCT) and several meta-analyses have been performed and are inspiring the current guidelines.
C. Spadaccio, U. Benedetto
semanticscholar +1 more source
ABSTRACT Background Intravascular lithotripsy (IVL) is increasingly used to treat coronary artery calcification (CAC). This study aimed to identify clinical and procedural factors associated with IVL treatment success. Methods This retrospective analysis included 454 patients (73 ± 9 years, 75% male) treated with IVL from the multicenter BENELUX‐IVL ...
Martijn J. H. van Oort+12 more
wiley +1 more source
Mehmet Akif Cakar1, Ersan Tatli2, Bilhan Ozalp2, Huseyin Gunduz11Sakarya Education and Research Hospital, Cardiology Department, Sakarya, Turkey; 2Ada Tip Private Hospital, Cardiology Department, Korucuk, Sakarya, TurkeyAbstract: Anomalous origin of the ...
Mehmet Akif Cakar+3 more
doaj
Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention [PDF]
Steven R. Steinhubl+7 more
openalex +1 more source
ABSTRACT Background There is limited evidence on the safety and efficacy of biodegradable‐polymer sirolimus‐eluting ultra‐thin stent (BP‐SES) in patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI). Aims This study aims to evaluate the clinical outcomes of HBR patients treated with BP‐SES and ≤ 30‐day dual ...
Andrea Erriquez+9 more
wiley +1 more source
Administration of Abciximab During Percutaneous Coronary Intervention Reduces Both Ex Vivo Platelet Thrombus Formation and Fibrin Deposition [PDF]
George Dangas+8 more
openalex +1 more source